Overview of bariatric and metabolic endoscopy interventions

Tawadros, Augustine; Makar, Michael; Kahaleh, Michel; Sarkar, Avik

doi:10.1177/2631774520935239

Cited by 9 publications

(8 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1 POSE uses an incisionless operating platform to create full-thickness plications in the gastric fundus, thereby reducing gastric volume, which, in turn, limits the quantity of food that can be consumed at a given time. 2 The procedure also causes antral dysmotility that prolongs satiety by inducing an earlier and longer feeling of gastric distention. In ESG, the endoscopist attempts to remodel the greater curvature of the stomach through the placement of full-thickness sutures.…”

Section: General Considerationsmentioning

confidence: 99%

“…It has been approved by the Food and Drug Administration for use in patients with a body mass index between 35 and 55 kg/m 2 . 2 Both the insertion and removal of this device are performed under deep sedation.…”

Section: General Considerationsmentioning

confidence: 99%

“…The AspireAssist device (Aspire Bariatrics Inc., King of Prussia, PA, USA) functions similar to a percutaneous endoscopic gastrostomy tube and allows the aspiration of portions of ingested food from the stomach. It has been approved by the Food and Drug Administration for use in patients with a body mass index between 35 and 55 kg/m 2 [ 2 ]. Both the insertion and removal of this device are performed under deep sedation.…”

Section: Endobariatricsmentioning

confidence: 99%

See 2 more Smart Citations

Anesthesia for Advanced Endoscopic Procedures

Goudra

Saumoy

2022

Clin Endosc

View full text Add to dashboard Cite

The gastrointestinal endoscopy paradigm is rapidly changing, and technological advancements are largely responsible. In tandem, anesthesia providers are adapting to the changing needs and demands. The challenges are unique. Complications arising from the procedures are both routine, such as aspiration and hypoxia, and procedure specific, such as bleeding, pneumothorax, pneumopericardium, and pneumoperitoneum. It is crucial for the anesthesia provider to have a good understanding of the techniques employed by the endoscopist. A higher index of suspicion is also essential to diagnose and appropriately manage many of the complications. In this review, an effort is made to discuss both procedural aspects and anesthesia challenges. We hope that both endoscopists and anesthesia providers will benefit from this review. Clin Endosc 2022 Jan 3. [Epub ahead of print]

show abstract

Section: General Considerationsmentioning

confidence: 99%

Section: General Considerationsmentioning

confidence: 99%

Section: Endobariatricsmentioning

confidence: 99%

See 1 more Smart Citation

Anesthesia for Advanced Endoscopic Procedures

Goudra

Saumoy

2022

Clin Endosc

View full text Add to dashboard Cite

show abstract

“…Bulking agent development for obesity treatment is largely undeveloped and perhaps a rich opportunity for much-needed bariatric treatment innovation, especially in combination with the growing field of endoscopic bariatrics. Bulking agents have the potential to limit nutrient absorption by being a physical barrier to mucosal absorption in a manner similar to other endoscopic methods of decreasing absorption such as duodenal mucosal resurfacing and intestinal bypass liners [57 ▪ ]. Other considerations for the future use of bulking agents, in a similar manner to its use for fecal incontinence, could be to create a pseudo-ileocecal valve in patients with significant bowel resection to slow transit, decrease diarrhea, and perhaps improve absorption.…”

Section: Future Directionsmentioning

confidence: 99%

Bulking agents in gastrointestinal endoscopy: present applications and future advances

Steinway

Singh

Akshintala

2022

Current Opinion in Gastroenterology

View full text Add to dashboard Cite

Purpose of reviewBulking agents are inert materials injected into an organ to affect the physical properties of the organ for a therapeutic purpose. Various agents have been developed to aid in the treatment of diseases like gastroesophageal reflux disease (GERD), fecal incontinence, obesity, malignancy, hemostasis, and tissue dissection. Here, we review the state of the art in bulking agents in gastrointestinal endoscopy, past failures, current limitations, and where we see the field heading in the future.Recent findingsThough bulking agents have been trialed for various different gastrointestinal diseases, there are currently limited uses in gastrointestinal endoscopy. Though various agents have been trialed for GERD, numerous complications and adverse events have limited its current use. However, for the treatment of fecal incontinence endoscopic bulking agent therapy is a reasonable option. Though in early stages of exploration, bulking agent therapy for enteric protection from radiotherapy may be a promising tool to improve treatment of pancreatic cancer. Bulking agents for tissue dissection have substantially improved lifting agents and complex polyp removal. Bulking agent therapy has not really been explored for endoscopic bariatric therapy or hemostasis but may be a fruitful area for exploration in the future.SummaryBulking agent therapy has been trialed for various gastrointestinal diseases with mixed success. There is currently a therapeutic roll in the endoscopic management of fecal incontinence and tissue dissection. A future role in the treatment of GERD, obesity, malignancy, and hemostasis seem feasible.

show abstract

“…This classification is based on the methods registered in the USA by the FDA. On the other hand, there are numerous methods today that lack American FDA registration but are registered and approved within the European Union, or are approved in the context of experimental studies [18,19].…”

Section: Introductionmentioning

confidence: 99%

Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy

et al. 2021

View full text Add to dashboard Cite

Obesity is a significant problem worldwide. Several serious diseases that decrease patient quality of life and increase mortality (high blood pressure, dyslipidaemia, type 2 diabetes etc.) are associated with obesity. Obesity treatment is a multidisciplinary and complex process that requires maximum patient compliance. Change of lifestyle is fundamental in the treatment of obesity. While pharmacotherapeutic options are available, their efficacy is limited. Surgical treatment though highly effective, carries the risk of complications and is thus indicated mostly in advanced stages of obesity. Endoscopic treatments of obesity are less invasive than surgical options, and are associated with fewer complications and nutritional deficits. Currently, there is a large spectrum of endoscopic methods based on the principles of gastric volume reduction, size restriction and gastric or small bowel bypass being explored with only few available in routine practice. The aim of this publication is to present an up-to-date summary of available endoscopic methods for the treatment of obesity focusing on their efficacy, safety and nutritional aspects.

show abstract

Overview of bariatric and metabolic endoscopy interventions

Cited by 9 publications

References 51 publications

Anesthesia for Advanced Endoscopic Procedures

Anesthesia for Advanced Endoscopic Procedures

Bulking agents in gastrointestinal endoscopy: present applications and future advances

Endoscopic Treatment of Obesity and Nutritional Aspects of Bariatric Endoscopy

Contact Info

Product

Resources

About